MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Imaging (Image Guided Surgery & Intraoperative Surgical Navigation, Planning, Training) Companies
Stereotaxis, Inc. (NASDAQ: STXS)
Organization & Developments: Stereotaxis
Parents
Stereotaxis, Inc. (NASDAQ: STXS)
Children
*Comprehensive range of products which are built around the technology of magnetics
*From the control room adjacent to the patient lab, or cath lab, and outside the x-ray field that is used for all types of interv
*Have introduced a new era in cardiac interventional medicine
*NIOBE® Magnetic Navigation System
*Physicians are able to conduct these procedures using a range of “point and click”, “joystick”, “push button” and “touch screen”
*Physicians may use partial or full automation of procedure protocols through the use of customized software.
*Proprietary Magnetically Enabled GentleTouch Catheters, Guidewires and Other Disposables
*Remotely perform computerized catheter-based interventional procedures.
*Stereotaxis
*Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias.
*User-Friendly Interface, The Proprietary Navigant™ Software User Interface
2022: Stereotaxis: Replacement Cycle Timeline Drives Prudent Guidance, Creates Compelling Opportunity_seekingalpha.com
2025: David Fischel: Surgical Robotics for Superhuman and Remote Operations
2025: Stereotaxis gets FDA nod for next-gen GenesisX surgical robot
2025: Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum
2025: Stereotaxis reiterates double-digit revenue growth outlook for 2025 as recurring revenue and MAGiC adoption ramp
2025: Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn
2025: Stereotaxis: Recurring Revenue Inflection
2025: Stock Market Sleeps On Stereotaxis MAGiC CE Mark_seekingalpha.com
2026: Stereotaxis Expands Endovascular Reach with $45M Robocath Acquisition
Jumps
*Key People: Stereotaxis
Finance & Acquisitions: Stereotaxis